These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1004155)

  • 1. The medicolegal significance of the package insert.
    Hirsh HL
    Med Trial Tech Q; 1976; 23(2):143-50. PubMed ID: 1004155
    [No Abstract]   [Full Text] [Related]  

  • 2. The medicolegal significance of the package insert.
    Hirsh HL
    Conn Med; 1978 Dec; 42(12):785-8. PubMed ID: 720048
    [No Abstract]   [Full Text] [Related]  

  • 3. The medicolegal significance of the package insert.
    Hirsh HL
    J Fam Pract; 1977 Jun; 4(6):1141-3. PubMed ID: 874441
    [No Abstract]   [Full Text] [Related]  

  • 4. The medicolegal significance of the package insert.
    Hirsh HL
    Urban Health; 1979 Mar; 8(2):35-7. PubMed ID: 10241525
    [No Abstract]   [Full Text] [Related]  

  • 5. The package insert and the pharmacist's liability.
    Simonsmeier LM
    Am J Pharm Sci Support Public Health; 1977; 149(3):82-9. PubMed ID: 596428
    [No Abstract]   [Full Text] [Related]  

  • 6. The new Food and Drug Administration drug package insert: implications for patient safety and clinical care.
    Watson KT; Barash PG
    Anesth Analg; 2009 Jan; 108(1):211-8. PubMed ID: 19095852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug reactions: the role of the package insert.
    Barnett FJ
    J Leg Med (N Y); 1973; 1(1):19-23. PubMed ID: 4548069
    [No Abstract]   [Full Text] [Related]  

  • 8. Power of the package insert.
    Chayet NL
    N Engl J Med; 1967 Dec; 277(23):1253-4. PubMed ID: 6072669
    [No Abstract]   [Full Text] [Related]  

  • 9. Incorrect or unsubstantiated indications listed for selected antimicrobials in the Physicians' Desk Reference.
    Rybak MJ; Gleckman R
    Am J Hosp Pharm; 1979 Jun; 36(6):738. PubMed ID: 463882
    [No Abstract]   [Full Text] [Related]  

  • 10. Prescription drug products; patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28-30. PubMed ID: 10324121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient package inserts: the proper prescription?
    Rowe HM
    Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988
    [No Abstract]   [Full Text] [Related]  

  • 12. Prescription drug products that require patient package inserts; ampicillin and phenytoin--Food and Drug Administration. Final rule.
    Fed Regist; 1981 Jan; 46(1):28. PubMed ID: 10249520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Package inserts, adverse drug reactions, and the physician's liability.
    Morrell MX
    Ration Drug Ther; 1975 Aug; 9(8):1-6. PubMed ID: 1144773
    [No Abstract]   [Full Text] [Related]  

  • 14. Kudos to the Food and Drug Administration: reversal of the package insert warning for birth defects for oral contraceptives.
    Brent RL
    Teratology; 1989 Jan; 39(1):93-4. PubMed ID: 2718144
    [No Abstract]   [Full Text] [Related]  

  • 15. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed NSAID package insert labeling.
    Food and Drug Administration U.S. Public Health Service
    J Pain Palliat Care Pharmacother; 2006; 20(1):49-55. PubMed ID: 16687359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FDA electronic drug labels to improve patient safety.
    J Pain Palliat Care Pharmacother; 2006; 20(2):96-7. PubMed ID: 16789334
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug use, the package insert, and the practice of medicine.
    Roth SH
    Arch Intern Med; 1982 May; 142(5):871-2. PubMed ID: 7082110
    [No Abstract]   [Full Text] [Related]  

  • 19. The Food and Drug Administration drug registration and listing system.
    Slavin M
    Drug Inf J; 1975; 9(2-3):239-40. PubMed ID: 10236978
    [No Abstract]   [Full Text] [Related]  

  • 20. Is it worth the trouble? The new policy on dissemination of information on off-label drug use under the Food and Drug Administration Modernization Act of 1997.
    Weeks EA
    Food Drug Law J; 1999; 54(4):645-65. PubMed ID: 11824459
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.